Targeting CTGF Overcomes Resistance to CSF1R Inhibitors by Preventing CAF Activation in Colorectal Cancer

Through imaging mass cytometry, researchers revealed that the CSF1R inhibitor PLX3397 indirectly activates cancer-associated fibroblasts, impedes T cell infiltration, and suppresses T cell function.